University researchers hope to improve the odds of surviving acute myeloid leukemia by loading a promising compound into nanoparticles that will target the inner recesses of bone marrow where leukemia stem cells lurk.
Medical Center researchers have shown for the first time how cancer-causing mutations control and alter the way cancer cells biosynthesize and replicate.
Neuroblastoma is one of the most common and deadly of childhood cancers, and Medical Center researchers have discovered that aggressive forms of the cancer contain a specific protein in their cells’ nuclei not found in more benign cases.
A study from the Wilmot Cancer Institute is believed to be the first to examine how leukemia stem cells change over time, and the first to look for several known gene biomarkers simultaneously.
Largely unreported in 2006 was the remarkable story of three Rochester virologists whose innovation, dedication, and perseverance resulted in the key breakthrough that lies at the heart of the first vaccine targeting the leading cause of cervical cancer.
Wilmot Cancer Institute discovered something simple and inexpensive to reduce pain and tingling in hands and feet due to chemotherapy—exercise.
A Wilmot Cancer Institute investigator discovered a gene that’s required for the initiation of melanoma and the growth of disseminated melanoma cancer cells in the lungs.
Jonathan Friedberg, a doctor at the Wilmot Cancer Center said the fact the president wants to make cancer research a national priority is exciting.
The School of Medicine and Dentistry houses the largest research resource of South African clawed frogs in the world, and researchers in Rochester and around the globe are using this frog model to better understand the minute details of how tumors grow and how the body reacts.